munchy360 and this is for the trolls that keep posting about funding for phase 1:
Quarterly coming up will show around 5 million in the bank which includes the R&D rebate. Based off AGN quarterly during their phase 1 and preparation for phase 2 they spent around 1.4 million dollars as shown below to get to phase 2. NYR has now a full runway all the way through phase 1 and into phase 2 plus non dilutive funding coming in after Walter Reed from US defence force and more non dilutive funding now coming from cardiovascular indication. 20 million market cap just plain stupid
Ann: NYR Completes Safety Studies Ahead of Phase I Clinical Trial, page-27
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.010(3.03%) |
Mkt cap ! $71.71M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.5¢ | 33.5¢ | $174.4K | 513.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40000 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 97442 | 5 |
View Market Depth
| Last trade - 15.59pm 28/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |